Literature DB >> 8795582

Tyrosine phosphorylation of 100-130 kDa proteins in lung cancer correlates with poor prognosis.

M Nishimura1, K Machida, M Imaizumi, T Abe, T Umeda, E Takeshima, T Watanabe, Y Ohnishi, K Takagi, M Hamaguchi.   

Abstract

To search for the signalling pathways in lung cancer relevant to its aggressive behaviour, we studied tyrosine phosphorylated proteins in lung cancer cell lines and surgical specimens. We found that the profiles of protein phosphorylation were closely matched among these cell lines and cancer tissues of different histological origins, and 100-130 kDa proteins were the major components of phosphorylated proteins. In surgical specimens, approximately half of the cases showed tyrosine phosphorylation of these proteins in a tumour-specific manner, and phosphorylation of these proteins showed good correlation with the survival length of patients after operation. By immunoprecipitation with specific antibodies, we found that p125FAK, p120 and beta-catenin were the major components of tyrosine-phosphorylated proteins in the surgical specimens. These results suggest that tyrosine phosphorylation of these proteins may play a role in tumour relapse and is available as a clinical marker.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795582      PMCID: PMC2074703          DOI: 10.1038/bjc.1996.436

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  27 in total

1.  A novel viral oncogene with structural similarity to phospholipase C.

Authors:  B J Mayer; M Hamaguchi; H Hanafusa
Journal:  Nature       Date:  1988-03-17       Impact factor: 49.962

2.  Phosphorylation of cellular proteins in Rous sarcoma virus-infected cells: analysis by use of anti-phosphotyrosine antibodies.

Authors:  M Hamaguchi; C Grandori; H Hanafusa
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

3.  Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: use in culture of primary solid lung tumors.

Authors:  J M Siegfried
Journal:  Cancer Res       Date:  1987-06-01       Impact factor: 12.701

4.  Epidermal growth factor receptors in lung tumours.

Authors:  M S Berger; W J Gullick; C Greenfield; S Evans; B J Addis; M D Waterfield
Journal:  J Pathol       Date:  1987-08       Impact factor: 7.996

5.  Epidermal growth factor receptor expression in human lung cancer cell lines.

Authors:  M Haeder; M Rotsch; G Bepler; C Hennig; K Havemann; B Heimann; K Moelling
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

6.  Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice.

Authors:  D Ilić; Y Furuta; S Kanazawa; N Takeda; K Sobue; N Nakatsuji; S Nomura; J Fujimoto; M Okada; T Yamamoto
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

7.  Somatomedin-C/insulin-like growth factor-I is a mitogen for human small cell lung cancer.

Authors:  V M Macauly; J D Teale; M J Everard; G P Joshi; I E Smith; J L Millar
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

8.  Epidermal growth factor receptors in non-small cell lung cancer.

Authors:  D Veale; T Ashcroft; C Marsh; G J Gibson; A L Harris
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

9.  Expression of epidermal growth factor receptor (EGF-R) in human lung tumours.

Authors:  T Cerny; D M Barnes; P Hasleton; P V Barber; K Healy; W Gullick; N Thatcher
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

10.  Thromboplastic and fibrinolytic activities of cultured human cancer cell lines.

Authors:  M Kinjo; K Oka; S Naito; S Kohga; K Tanaka; S Oboshi; Y Hayata; K Yasumoto
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

View more
  5 in total

1.  The prognostic significance of focal adhesion kinase expression in stage I non-small-cell lung cancer.

Authors:  Grace K Dy; Lourdes Ylagan; Saraswati Pokharel; Austin Miller; Elizabeth Brese; Wiam Bshara; Carl Morrison; William G Cance; Vita M Golubovskaya
Journal:  J Thorac Oncol       Date:  2014-09       Impact factor: 15.609

Review 2.  Focal adhesion kinase as a cancer therapy target.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

3.  Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis.

Authors:  Y Gong; T Hirano; Y Kato; K Yoshida; Y Shou; T Ohira; N Ikeda; Y Ebihara; H Kato
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

4.  Tumor-specific activation of mitogen-activated protein kinase in human colorectal and gastric carcinoma tissues.

Authors:  Y Kuno; K Kondo; H Iwata; T Senga; S Akiyama; K Ito; H Takagi; M Hamaguchi
Journal:  Jpn J Cancer Res       Date:  1998-09

5.  Increased Expression and Activation of FAK in Small-Cell Lung Cancer Compared to Non-Small-Cell Lung Cancer.

Authors:  Frank Aboubakar Nana; Delphine Hoton; Jérôme Ambroise; Marylène Lecocq; Marie Vanderputten; Yves Sibille; Bart Vanaudenaerde; Charles Pilette; Caroline Bouzin; Sebahat Ocak
Journal:  Cancers (Basel)       Date:  2019-10-10       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.